Overview
Total raised
$20.21M
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Mar 20, 2025 | Funding round | $8.68M |
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 21, 2025 | Flexvelop's Leap: A FinTech Transformation Fueled by €44 Million Investment | In the bustling world of FinTech, where innovation meets necessity, Flexvelop has emerged as a beacon of change. This Hamburg-based startup, founded in 2018, has recently secured a substantial €44 million in funding. This investment marks a... |
| Mar 21, 2025 | The Future of Medicine: AI and Biotech Revolutionize Diagnostics and Drug Development | In the realm of healthcare, change is the only constant. Two recent breakthroughs illustrate this truth vividly. One focuses on sleep disorders linked to Parkinson's disease, while the other aims to revolutionize cancer drug development. Bo... |
| Mar 21, 2025 | 8 Millionen für Biotech-Startup BioCopy | BioCopy beabsichtigt wirksamere Krebsmedikamente in kürzester Zeit und zu deutlich niedrigeren Kosten herzustellen. Im Fokus steht die Entwicklung von Biotherapeutika der nächsten Generation gegen Lungen-, Blasen- und Ovarialkarzinome. «Mi... |
| Mar 20, 2025 | BioCopy raises €8M to cut cancer drug development from years to months | The German-Swiss biotech BioCopy has secured €8 million in funding. BioCopy focuses on the discovery and development of biotherapeutic drugs using an automated, AI-assisted end-to-end platform and is developing next-generation biotherapeuti... |
| Mar 20, 2025 | Flexvelop erhält 44 Millionen – buynomics sammelt 30 Millionen ein – theion bekommt 15 Millionen | Im #DealMonitor für den 20. März werfen wir einen Blick auf die wichtigsten, spannendsten und interessantesten Investments und Exits des Tages in der DACH-Region. Alle Deals der Vortage gibt es im großen und übersichtlichen #DealMonitor-Arc... |
| Jul 17, 2024 | BioCopy Chooses Genedata for AI-Powered Multispecific Antibody Discovery | Digitalizing Biopharma R&D: The Genedata Biopharma Platform is the #1 enterprise software system for achieving operational excellence in biopharma R&D. Cutting-edge biotech builds on best-in-class software to automate R&D workfl... |
Reviews 0
FAQ about BioCopy
How much funding has BioCopy raised?
BioCopy has raised $20.21M in total across 2 funding rounds.
What funding rounds has BioCopy raised?
Parsers VC lists 2 funding rounds of BioCopy, among them a funding round of $8.68M on Mar 20, 2025.
What has the press written about BioCopy?
Parsers VC has collected 7 articles mentioning BioCopy, among them “Flexvelop's Leap: A FinTech Transformation Fueled by €44 Million Investment” (Mar 21, 2025) and “The Future of Medicine: AI and Biotech Revolutionize Diagnostics and Drug Development” (Mar 21, 2025).
Is BioCopy still active?
Yes, BioCopy is active; its latest activity on Parsers VC dates from May 1, 2026.